You just read:

Boston Biomedical, Inc. Announces Presentations for Investigational Agents Napabucasin and DSP-7888 (ombipepimut-S*) to be Featured at ASCO 2018

News provided by

Boston Biomedical, Inc.

May 17, 2018, 09:51 ET